Index Entries

Tomás M. León, Vajeera Dorabawila, Lauren Nelson, Emily Lutterloh, Ursula E. Bauer, Bryon Backenson, Mary T. Bassett, Hannah Henry, Brooke Bregman, Claire M. Midgley, Jennifer F. Myers, Ian D. Plumb, Heather E. Reese, Rui Zhao, Melissa Briggs-Hagen, Dina Hoefer, James P. Watt, Benjamin J. Silk, Seema Jain, and Eli S. Rosenberg
January 19, 2022
CDC (Centers for Disease Control & Prevention)

Summary

What is added by this report? During May–November 2021, case and hospitalization rates were highest among persons who were unvaccinated without a previous diagnosis. Before Delta became the predominant variant in June, case rates were higher among persons who survived a previous infection than persons who were vaccinated alone. By early October, persons who survived a previous infection had lower case rates than persons who were vaccinated alone..."

Main Text
 
"To examine the impact of primary COVID-19 vaccination and previous SARS-CoV-2 infection on COVID-19 incidence and hospitalization rates, statewide testing, surveillance, and COVID-19 immunization data from California and New York (which account for 18% of the U.S. population) were analyzed… By the week beginning October 3, compared with COVID-19 cases rates among unvaccinated persons without a previous COVID-19 diagnosis, case rates among vaccinated persons without a previous COVID-19 diagnosis were 6.2-fold (California) and 4.5-fold (New York) lower; rates were substantially lower among both groups with previous COVID-19 diagnoses, including 29.0-fold (California) and 14.7-fold lower (New York) among unvaccinated persons with a previous diagnosis, and 32.5-fold (California) and 19.8-fold lower (New York) among vaccinated persons with a previous diagnosis of COVID-19. During the same period, compared with hospitalization rates among unvaccinated persons without a previous COVID-19 diagnosis, hospitalization rates in California followed a similar pattern. These results demonstrate that vaccination protects against COVID-19 and related hospitalization, and that surviving a previous infection protects against a reinfection and related hospitalization. Importantly, infection-derived protection was higher after the Delta variant became predominant, a time when vaccine-induced immunity for many persons declined because of immune evasion and immunologic waning.”

document
breakthrough cases,COVID-19,natural immunity,vaccine systemic and virological concerns,vaccines